# Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer

> **NCT02240524** · PHASE3 · UNKNOWN · sponsor: **Affiliated Cancer Hospital & Institute of Guangzhou Medical University** · enrollment: 582 (estimated)

## Conditions studied

- Advanced Gastric Adenocarcinoma

## Interventions

- **PROCEDURE:** D2 lymphadenectomy
- **PROCEDURE:** Systemic chemotherapy
- **PROCEDURE:** HIPEC

## Key facts

- **NCT ID:** NCT02240524
- **Lead sponsor:** Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 582 (ESTIMATED)
- **Last updated:** 2014-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02240524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02240524, "Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02240524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
